BCLAF3
BCLAF1 and THRAP3 family member 3
Also known as: BCLA3_HUMAN, CXorf23
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A2AJT9
- Gene
- BCLAF3
- Ensembl
- ENSG00000173681
- Chromosome
- X
- Canonical length
- 711 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA binding activity and transcription coregulator activity. Predicted to be involved in positive regulation of transcription by RNA polymerase II. Predicted to be located in mitochondrion. Predicted to be part of mediator complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
711 residues, UniProt reviewed canonical sequence.
>A2AJT9|BCLAF3
1 MARSRSRSPR WKHRSLSPVP RNAEHYKQRH SHGHYGCEYR KDPKRPVAWR MDSEKHGQSK
61 PRIPSRGNIY YQSYEHRSPS PNIRNSLENV YMYKPHRGYS PGRGDSNRRA QYMPKYSEGI
121 PYKEHERNSY PQKVQGGHSP DDHRVRGSGK GGKPPQRSIA DSFRFEGKWH EDELRHQRIQ
181 EEKYSQSTRR GSEDFETRSS FQKRYPEDRD FRKYGHTSKR PKDVERYESR EPARNPKWKP
241 EHSLPPYQED TDQWNLGPQT YRHAEREHPE TSSATKVSYD YRHKRPKLLD GDQDFSDGRT
301 QKYCKEEDRK YSFQKGPLNR ELDCFNTGRG RETQDGQVKE PFKPSKKDSI ACTYSNKNDV
361 DLRSSNDKWK EKIKKEGDCR KESNSSSNQL DKSQKLPDVK PSPINLRKKS LTVKVDVKKT
421 VDTFRVASSY STERQMSHDL VAVGRKSENF HPVFEHLDST QNTENKPTGE FAQEIITIIH
481 QVKANYFPSP GITLHERFST MQDIHKADVN EIPLNSDPEI HRRIDMSLAE LQSKQAVIYE
541 SEQTLIKIID PNDLRHDIER RRKERLQNED EHIFHIASAA ERDDQNSSFS KVKNVHTDGF
601 QKPTHFIKSN FRKCIEKPYM NYTTQRKDII THKPFEVEGN HRNTRVRPFK SNFRGGRCQP
661 NYKSGLVQKS LYIQAKYQRL RFTGPRGFIT HKFRERLMRK KKEYTDVATG ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCLAF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 6.7 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 6.7 nTPM
- cerebellum: 6.2 nTPM
- retina: 5.2 nTPM
- skin: 5.1 nTPM
- endometrium: 4.3 nTPM
- blood vessel: 4.2 nTPM
Single-cell type
- neutrophils: 142 nCPM
- pituicytes/fscs: 105 nCPM
- myonuclei: 98 nCPM
- distal convoluted tubule cells: 79 nCPM
- adipocytes: 78 nCPM
- bergmann glia: 78 nCPM
Immune cell
- basophil: 1.4 nTPM
- neutrophil: 1.2 nTPM
- naive B-cell: 0.6 nTPM
- plasmacytoid DC: 0.6 nTPM
- gdT-cell: 0.4 nTPM
- memory CD8 T-cell: 0.4 nTPM
Brain region
- cerebellum: 27 nTPM
- cerebral cortex: 19 nTPM
- white matter: 18 nTPM
- thalamus: 18 nTPM
- hippocampal formation: 18 nTPM
- medulla oblongata: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.63
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCLAF3 as an antibody target. Whether an autoantibody or antibody against BCLAF3 could matter depends on whether native BCLAF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCLAF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCLAF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...